MENU
+Compare
HLOSF
Stock ticker: OTC
AS OF
May 30 closing price
Price
$3.17
Change
+$0.92 (+40.89%)
Capitalization
316.87M

HLOSF HEALIOS K K Forecast, Technical & Fundamental Analysis

Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products... Show more

HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HLOSF with price predictions
Jun 27, 2025

HLOSF's Stochastic Oscillator remains in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 18 cases where HLOSF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for HLOSF turned negative on June 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 10 similar instances when the indicator turned negative. In of the 10 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HLOSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (23.810) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). HLOSF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (71.429) is also within normal values, averaging (252.247).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLOSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
World Trade Center Bldg. 15th Floor
Phone
N/A
Employees
108
Web
https://www.healios.co.jp
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIERX13.070.14
+1.08%
RBC International Equity R6
MDFOX8.250.06
+0.73%
BlackRock Large Cap Focus Growth Inv A
MPGSX11.640.08
+0.69%
MassMutual Disciplined Gr R5
DSMFX13.290.01
+0.08%
Destinations Small-Mid Cap Equity I
FDVLX13.600.01
+0.07%
Fidelity Value

HLOSF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HLOSF has been loosely correlated with ORKA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if HLOSF jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
ORKA - HLOSF
62%
Loosely correlated
-4.73%
PCVX - HLOSF
39%
Loosely correlated
-0.91%
CYYNF - HLOSF
39%
Loosely correlated
N/A
FHTX - HLOSF
23%
Poorly correlated
-0.41%
DMAC - HLOSF
22%
Poorly correlated
+0.79%
More